Ignite Creation Date:
2024-05-06 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05712902
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-06
First Post:
2023-01-12
Brief Title:
DZD9008 in Pretreated Lung Cancer Patients With EGFR Exon20 Insertion Mutation
Sponsor:
Dizal Pharmaceuticals
Organization:
Dizal Pharmaceuticals
Organization Data
Organization:
Dizal Pharmaceuticals
Class:
INDUSTRY
Study ID:
DZ2020E0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dizal Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None